Detalhe da pesquisa
1.
Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.
J Cell Physiol
; 230(1): 131-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24911215
2.
Nexavar/Stivarga and viagra interact to kill tumor cells.
J Cell Physiol
; 230(9): 2281-98, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25704960
3.
Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
Mol Pharmacol
; 84(2): 171-81, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23661648
4.
Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells.
Mol Pharmacol
; 84(4): 562-71, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23877009
5.
Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells.
J Cell Physiol
; 228(10): 1996-2005, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23674352
6.
Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.
Nat Med
; 12(8): 955-60, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16892038
7.
Obatoclax and lapatinib interact to induce toxic autophagy through NOXA.
Mol Pharmacol
; 81(4): 527-40, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22219388
8.
Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors.
Mol Pharmacol
; 82(2): 322-32, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22596349
9.
Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1.
Mol Pharmacol
; 81(5): 748-58, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357666
10.
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
Mol Pharmacol
; 79(3): 368-80, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21119025
11.
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.
Mol Ther
; 18(6): 1130-42, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20179672
12.
Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
Mol Pharmacol
; 77(2): 298-310, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19910452
13.
MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.
Anticancer Drugs
; 21(8): 725-31, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20613485
14.
Pazopanib and HDAC inhibitors interact to kill sarcoma cells.
Cancer Biol Ther
; 15(5): 578-85, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24556916
15.
The role of cell signalling in the crosstalk between autophagy and apoptosis.
Cell Signal
; 26(3): 549-55, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24308968
16.
Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.
Cancer Biol Ther
; 14(10): 982-96, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025251
17.
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells.
Cancer Biol Ther
; 14(11): 1039-49, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24025359
18.
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing.
Cancer Biol Ther
; 13(4): 224-36, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22354011
19.
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
Cancer Biol Ther
; 13(7): 567-74, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22406992
20.
Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling.
Cancer Biol Ther
; 13(9): 793-803, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22673740